tiprankstipranks
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market
GLUE
Monte Rosa Therapeutics
RESEARCH TOOLSreports

Monte Rosa Therapeutics (GLUE) Financial Statements

Compare
380 Followers

Monte Rosa Therapeutics Financial Overview

Monte Rosa Therapeutics's market cap is currently $1.25B. The company's EPS TTM is $-0.54; its P/E ratio is -5.57; Monte Rosa Therapeutics is scheduled to report earnings on March 17, 2026, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 123.67M$ 75.62M$ 0.00$ 0.00$ 0.00
Gross Profit$ 115.32M$ 67.50M$ -6.22M$ -8.56M$ 0.00
Operating Income$ -54.21M$ -81.11M$ -143.31M$ -112.38M$ -72.88M
EBITDA$ -45.85M$ -72.99M$ -137.09M$ -108.64M$ -70.75M
Net Income$ -38.63M$ -72.70M$ -135.35M$ -108.50M$ -73.96M
Balance Sheet
Cash & Short-Term Investments$ 377.10M$ 372.15M$ 232.41M$ 262.83M$ 346.07M
Total Assets$ 448.66M$ 438.73M$ 303.75M$ 342.39M$ 366.33M
Total Debt$ 39.19M$ 42.72M$ 46.04M$ 47.00M$ 0.00
Net Debt$ -90.69M$ -181.54M$ -82.06M$ -7.91M$ -346.07M
Total Liabilities$ 215.60M$ 215.80M$ 124.50M$ 70.98M$ 18.81M
Stockholders' Equity$ 233.06M$ 222.94M$ 179.25M$ 271.41M$ 347.51M
Cash Flow
Free Cash Flow$ -27.50M$ 38.01M$ -62.84M$ -105.38M$ -69.09M
Operating Cash Flow$ -22.80M$ 42.00M$ -43.80M$ -92.47M$ -59.36M
Investing Cash Flow$ -101.83M$ -44.45M$ 88.80M$ -219.22M$ -9.65M
Financing Cash Flow$ 30.35M$ 98.89M$ 27.49M$ 20.47M$ 377.56M
Currency in USD

Monte Rosa Therapeutics Earnings and Revenue History

Income Statement >

Monte Rosa Therapeutics Debt to Assets

Balance Sheet >

Monte Rosa Therapeutics Cash Flow

Cash Flow >

Monte Rosa Therapeutics Forecast EPS vs Actual EPS

Earnings >